BIBLIOGRAPHY
This new section of the site is dedicated to articles related to lamivudine, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.
J Acquir Immune Defic Syndr 2007 Dec;46(5):547-54
Renal Fanconi syndrome and myopathy after liver transplantation: Drug-related mitochondrial cytopathy?
Pediatr Transplant 2008 Feb;12(1):109-12
Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
J Viral Hepat 2008 Feb;15(2):108-14
Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.
J Viral Hepat 2008 Feb;15(2):89-102
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
Clin Infect Dis 2008 Feb;46(3):e28-30